BMC Infectious Diseases

official impact factor 2.83

Open Access Research article

Impact of Empiric Antimicrobial Therapy on Outcomes in Patients with Escherichia coli and Klebsiella pneumoniae Bacteremia: A Cohort Study

Kerri A Thom1*, Marin L Schweizer1, Regina B Osih2, Jessina C McGregor3, Jon P Furuno1, Eli N Perencevich1,4 and Anthony D Harris1

Author Affiliations

1 Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

2 Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland

3 College of Pharmacy, Oregon State University, Portland, OR, USA

4 Vetrans Affairs Maryland Health Care System, Baltimore, MD, USA

For all author emails, please log on.

BMC Infectious Diseases 2008, 8:116 doi:10.1186/1471-2334-8-116

Published: 15 September 2008

Additional files

Additional file 1:

Antimicrobial Susceptibilities of Escherichia coli and Klebsiella Bloodstream Isolates. This table includes the antimicrobial sensitivity patterns of the Escherichia coli and Klebsiella bloodstream isolates reported in this paper.

Format: DOC Size: 29KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data